TD Cowen on Palvella Therapeutics' (PVLA) SELVA Data Preview: 'High Conviction for Success'
Tweet Send to a Friend
TD Cowen analyst Ritu Baral reiterated a Buy rating and $133.00 price target on Palvella Therapeutics (NASDAQ: PVLA).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
